Loomis Sayles & Co. L P raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,050,549 shares of the company's stock after purchasing an additional 28,790 shares during the quarter. Loomis Sayles & Co. L P owned 0.62% of Option Care Health worth $24,372,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health during the 4th quarter worth $26,000. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the period. Quarry LP raised its holdings in shares of Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares in the last quarter. Finally, Blue Trust Inc. lifted its stake in Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after acquiring an additional 681 shares during the period. 98.05% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
OPCH has been the topic of a number of research reports. JMP Securities reissued a "market outperform" rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Barrington Research boosted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target on the stock. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus target price of $33.00.
Read Our Latest Research Report on OPCH
Insider Activity at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.
Option Care Health Stock Up 0.6 %
Shares of OPCH traded up $0.22 during midday trading on Monday, hitting $34.95. 1,527,150 shares of the company's stock traded hands, compared to its average volume of 1,713,078. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.74 billion, a price-to-earnings ratio of 29.37, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm's fifty day moving average is $32.47 and its 200-day moving average is $28.38.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
